Gilead Sciences Short Interest Ratio and Short Volume

Gilead Sciences (NASDAQ:GILD) Short Interest Frequently Asked Questions

What is Gilead Sciences' current short interest?

Short interest is the volume of Gilead Sciences shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 24,280,000 shares of GILD short. Learn More on Gilead Sciences' current short interest.

What is a good short interest ratio for Gilead Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Gilead Sciences currently has a short interest ratio of 4.0. Learn More on a good short interest ratio for Gilead Sciences

Which institutional investors are shorting Gilead Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gilead Sciences: Clear Street Markets LLC, Bank of America Corp DE, HBK Investments L P, Pathstone Family Office LLC, Marshall Wace LLP, Jefferies Group LLC, Wells Fargo & Company MN, Walleye Trading LLC, Logan Capital Management Inc., Millennium Management LLC, Pathstone Family Office LLC, Parallax Volatility Advisers L.P., Balyasny Asset Management LLC, Citadel Advisors LLC, Squarepoint Ops LLC, Bank of America Corp DE, SG3 Management LLC, Royal Bank of Canada, Capital Markets Trading UK LLP, Credit Suisse AG, Maven Securities LTD, Jefferies Group LLC, HBK Investments L P, Capula Management Ltd, Goldman Sachs Group Inc., Marshall Wace LLP, Allianz Asset Management GmbH, PEAK6 Investments LLC, DCF Advisers LLC, Public Sector Pension Investment Board, SG Americas Securities LLC, JPMorgan Chase & Co., Simplex Trading LLC, Bank of Montreal Can, Capital Fund Management S.A., HAP Trading LLC, Susquehanna International Group LLP, Group One Trading L.P., BNP Paribas Arbitrage SA, Citigroup Inc., Wolverine Trading LLC, IMC Chicago LLC, Private Capital Management LLC, Clear Street Markets LLC, and Cutler Group LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Gilead Sciences' short interest increasing or decreasing?

Gilead Sciences saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 24,280,000 shares, an increase of 16.2% from the previous total of 20,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Gilead Sciences' short interest compare to its competitors?

0.00% of Gilead Sciences' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Gilead Sciences: Amgen Inc. (1.96%), Regeneron Pharmaceuticals, Inc. (1.76%), Vertex Pharmaceuticals Incorporated (1.97%), Biogen Inc. (1.68%), Seagen Inc. (1.78%), Alnylam Pharmaceuticals, Inc. (0.00%), Exact Sciences Co. (0.00%), Repligen Co. (3.29%), Incyte Co. (2.52%), and BioMarin Pharmaceutical Inc. (5.96%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short Gilead Sciences stock?

Short selling GILD is an investing strategy that aims to generate trading profit from Gilead Sciences as its price is falling. Gilead Sciences' stock is trading up $0.25 today. To short Gilead Sciences stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Gilead Sciences will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Gilead Sciences?

A short squeeze for Gilead Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GILD, which in turn drives the price of the stock up even further.

How often is Gilead Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GILD, twice per month. The most recent reporting period available is September, 30 2021.